The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
Official Title: Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
Study ID: NCT01574170
Brief Summary: This is a biomedical study of interventional type. The trial will include 270 patients (180 patients in the first cohort and 90 patients in a second cohort) over a period of 3 years + 2 years of follow up. This prospective study will be conduct in patients who will receive a third line chemotherapy for metastatic breast cancer. The main objective of the study (first cohort) is to identify patients who benefit from a third line treatment in terms of overall survival with a score established from clinical, histological, but also biological "classic" and "innovative" (account of circulating tumor cells) criteria, all of these criteria must be measurable before the introduction of the 3rd line. This score will then be validated on the 2nd cohort. There will be no interruption of inclusions between first and second cohort of patients
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
C.M.C.O. Claude Bernard, Albi, , France
Institut de Cancérologie de l'Ouest Paul Papin, Angers, , France
CHU Jean Minjoz, Besançon, , France
CHRU Brest, Brest, , France
Centre Hospitalier Jean Rougier, Cahors, , France
Centre Hospitalier Intercommunal de Castres-Mazamet, Castres, , France
Centre d'Oncologie et de Radiothérapie du Parc, Dijon, , France
Centre Georges François Leclerc, Dijon, , France
Clinique La Croix du Sud, Quint-fonsegrives, , France
Centre Eugène Marquis, Rennes, , France
Centre Hospitalier de Rodez, Rodez, , France
Centre Paul Strauss, Strasbourg, , France
Polyclinique de l'Ormeau, Tarbes, , France
CHU Rangueil, Toulouse, , France
Institut Claudius Regaud, Toulouse, , France
Institut de Cancérologie de Lorraine, Vandoeuvre Les Nancy, , France
Name: Florence MD DALENC
Affiliation: Institut Claudius Regaud
Role: PRINCIPAL_INVESTIGATOR